Rep. April McClain Delaney Buys Shares of BWX Technologies, Inc. (NYSE:BWXT)

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of BWX Technologies, Inc. (NYSE:BWXT). In a filing disclosed on August 03rd, the Representative disclosed that they had bought between $15,001 and $50,000 in BWX Technologies stock on July 24th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Life Time Group (NYSE:LTH) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) on 7/31/2026.
• Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of C.H. Robinson Worldwide (NASDAQ:CHRW) on 7/31/2026.
• Sold $1,001 – $15,000 in shares of STERIS (NYSE:STE) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of Somnigroup International (NYSE:SGI) on 7/30/2026.
• Purchased $1,001 – $15,000 in shares of Entegris (NASDAQ:ENTG) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/30/2026.
• Purchased $1,001 – $15,000 in shares of Life Time Group (NYSE:LTH) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Service Corporation International (NYSE:SCI) on 7/30/2026.

BWX Technologies Stock Performance

Shares of BWX Technologies stock opened at $172.19 on Wednesday. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.58. BWX Technologies, Inc. has a twelve month low of $157.10 and a twelve month high of $241.82. The stock has a market cap of $15.77 billion, a price-to-earnings ratio of 46.04, a P/E/G ratio of 2.96 and a beta of 0.76. The company’s fifty day moving average is $186.82 and its 200 day moving average is $201.30.

BWX Technologies (NYSE:BWXT) last announced its earnings results on Monday, August 3rd. The technology company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.03. BWX Technologies had a return on equity of 31.34% and a net margin of 10.11%.The business had revenue of $901.62 million during the quarter, compared to analyst estimates of $902.41 million. During the same period last year, the company earned $1.02 EPS. BWX Technologies’s revenue for the quarter was up 18.0% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. Sell-side analysts forecast that BWX Technologies, Inc. will post 4.61 EPS for the current year.

BWX Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Tuesday, August 18th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, August 18th. BWX Technologies’s payout ratio is 28.88%.

Analyst Ratings Changes

BWXT has been the subject of a number of recent analyst reports. Weiss Ratings downgraded shares of BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, July 29th. JPMorgan Chase & Co. started coverage on shares of BWX Technologies in a report on Monday, July 27th. They issued an “overweight” rating and a $230.00 target price on the stock. Seaport Research Partners raised shares of BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price objective for the company in a research report on Monday, June 22nd. Wall Street Zen raised BWX Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Truist Financial lifted their price objective on shares of BWX Technologies from $205.00 to $212.00 and gave the company a “hold” rating in a report on Monday, May 11th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, BWX Technologies currently has an average rating of “Moderate Buy” and an average price target of $228.20.

Key Headlines Impacting BWX Technologies

Here are the key news stories impacting BWX Technologies this week:

• Positive Sentiment: BWXT reported second-quarter EPS of $1.07, exceeding the $1.04 consensus estimate, while revenue increased 18% year over year to approximately $901.6 million. Strong execution and commercial operations growth supported management’s more optimistic outlook. BWXT Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised 2026 adjusted EPS guidance to $4.70-$4.80 and increased free-cash-flow guidance to $345 million-$360 million. The improved outlook reflects stronger operations and reinforces the company’s earnings and cash-generation prospects. BWXT Raises EPS and Free Cash Flow Outlook
• Positive Sentiment: BWXT agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million, while retaining a minority stake. The divestiture should provide liquidity for expansion in nuclear components, naval propulsion, and small modular reactors, creating a more focused nuclear and defense profile. BWXT Medical Business Sale
• Positive Sentiment: BTIG reaffirmed a Buy rating with a $235 price target, while Northland Securities modestly increased its FY2026 and FY2027 EPS forecasts to $4.71 and $5.17, respectively. These revisions suggest analysts see additional earnings growth ahead.
• Neutral Sentiment: BWXT maintained its quarterly dividend at $0.27 per share, payable September 4, with an ex-dividend date of August 18. The roughly 0.6% yield provides a modest shareholder return but is unlikely to be a major valuation driver.
• Negative Sentiment: Northland cut its Q3 2026 EPS estimate to $1.18 from $1.22, indicating some expected near-term variability. BWXT also trades at a relatively high valuation, with a P/E near 46, leaving the stock sensitive to execution issues, delayed reactor projects, regulatory hurdles, or pressure on margins during capacity expansion.

Insider Transactions at BWX Technologies

In related news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $209.25, for a total transaction of $505,757.25. Following the completion of the transaction, the chief financial officer owned 6,884 shares in the company, valued at approximately $1,440,477. This represents a 25.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Rex D. Geveden sold 10,000 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares in the company, valued at approximately $41,472,181.71. The trade was a 4.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On BWX Technologies

Hedge funds have recently modified their holdings of the company. Invesco Ltd. grew its holdings in shares of BWX Technologies by 0.7% in the fourth quarter. Invesco Ltd. now owns 2,568,117 shares of the technology company’s stock valued at $443,873,000 after acquiring an additional 18,967 shares in the last quarter. Franklin Resources Inc. boosted its position in BWX Technologies by 2.4% in the fourth quarter. Franklin Resources Inc. now owns 2,258,282 shares of the technology company’s stock worth $390,321,000 after purchasing an additional 53,594 shares during the last quarter. Geode Capital Management LLC boosted its position in BWX Technologies by 3.9% in the fourth quarter. Geode Capital Management LLC now owns 1,857,716 shares of the technology company’s stock worth $321,176,000 after purchasing an additional 69,857 shares during the last quarter. Blair William & Co. IL grew its stake in BWX Technologies by 20.9% in the 4th quarter. Blair William & Co. IL now owns 1,439,666 shares of the technology company’s stock valued at $248,832,000 after purchasing an additional 248,598 shares during the period. Finally, First Trust Advisors LP increased its position in shares of BWX Technologies by 12.2% during the 1st quarter. First Trust Advisors LP now owns 1,391,079 shares of the technology company’s stock valued at $284,462,000 after purchasing an additional 151,580 shares during the last quarter. Institutional investors own 94.39% of the company’s stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.